Clinically relevant HOCl concentrations reduce clot retraction rate via the inhibition of energy production in platelet mitochondria

References

• Eiserich JP, Hristova M, Cross CE, Jones AD, Freeman BA ,Halliwell B, van der Vliet A. Formation of nitric oxide- derived inflammatory oxidants by myeloperoxidase in neutrophils. Nature 1998;391:393–397.
   PubMed Web of Science ®Google Scholar
• Nauseef WM. Insights into myeloperoxidase biosynthesis from its inherited deficiency. J Mol Med (Berl) 1998;76: 661–668.
   PubMed Web of Science ®Google Scholar
• Weiss SJ. Tissue destruction by neutrophils. N Engl J Med 1989 9;320:365–376.
   PubMed Web of Science ®Google Scholar
• Pullar JM, Vissers MC, Winterbourn CC. Living with a killer: the effects of hypochlorous acid on mammalian cells. IUBMB Life 2000;50:259–266.
   PubMed Web of Science ®Google Scholar
• Hampton MB, Kettle AJ, Winterbourn CC. Inside the neutrophil phagosome: oxidants, myeloperoxidase, and bacterial killing. Blood 1998;92:3007–3017.
   PubMed Web of Science ®Google Scholar
• Brennan ML, Penn MS, Van Lente F, Nambi V, Shishehbor MH, Aviles RJ, et al. Prognostic value of myeloperoxidase in patients with chest pain. N Engl J Med 2003;349: 1595–1604.
   PubMed Web of Science ®Google Scholar
• Mocatta TJ, Pilbrow AP, Cameron VA, Senthilmohan R, Frampton CM, Richards AM, Winterbourn CC. Plasma concentrations of myeloperoxidase predict mortality after myocardial infarction. J Am Coll Cardiol 2007;49:1993–2000.
   PubMed Web of Science ®Google Scholar
• Baldus S, Heeschen C, Meinertz T, Zeiher AM, Eiserich JP, Münzel T, et al. Myeloperoxidase serum levels predict risk in patients with acute coronary syndromes. Circulation 2003;108:1440–1445.
   PubMed Web of Science ®Google Scholar
• Podrez EA, Abu-Soud HM, Hazen SL. Myeloperoxidase-generated oxidants and atherosclerosis. Free Radic Biol Med 2000;28:1717–1725.
   PubMed Web of Science ®Google Scholar
• Malech HL, Gallin JI. Current concepts: immunology. Neutrophils in human diseases. N Engl J Med 1987;317:687–694.
   PubMed Web of Science ®Google Scholar
• Malle E, Buch T, Grone HJ. Myeloperoxidase in kidney disease. Kidney Int 2003;64:1956–1967.
   PubMed Web of Science ®Google Scholar
• Ohshima H, Tatemichi M, Sawa T. Chemical basis of inflammation-induced carcinogenesis. Arch Biochem Biophys 2003;417:3–11.
   PubMed Web of Science ®Google Scholar
• Schiller J, Fuchs B, Arnhold J, Arnold K. Contribution of reactive oxygen species to cartilage degradation in rheumatic diseases: molecular pathways, diagnosis and potential therapeutic strategies. Curr Med Chem 2003;10:2123–2145.
   PubMed Web of Science ®Google Scholar
• Hazen SL, Crowley JR, Mueller DM, Heinecke JW. Mass spectrometric quantification of 3-chlorotyrosine in human tissues with attomole sensitivity: a sensitive and specific marker for myeloperoxidase-catalyzed chlorination at sites of inflammation. Free Radic Biol Med 1997;23:909–916.
   PubMed Web of Science ®Google Scholar
• Himmelfarb J, McMenamin ME, Loseto G, Heinecke JW. Myeloperoxidase-catalyzed 3-chlorotyrosine formation in dialysis patients. Free Radic Biol Med 2001;31:1163–1169.
   PubMed Web of Science ®Google Scholar
• Mohiuddin I, Chai H, Lin PH, Lumsden AB, Yao Q, Chen C. Nitrotyrosine and chlorotyrosine: clinical significance and biological functions in the vascular system. J Surg Res 2006;133:143–149.
   PubMed Web of Science ®Google Scholar
• Stief TW, Kurz J, Doss MO, Fareed J. Singlet oxygen inactivates fibrinogen, factor V, factor VIII, factor X, and platelet aggregation of human blood. Thromb Res 2000;97:473–480.
   PubMed Web of Science ®Google Scholar
• Murina MA, Savel'eva EL, Roshchupkin DI. Mechanism of action of biogenic chloramines and hypochlorite on initial aggregation of blood platelets. Biofizika 2006;51:299–305.
   Google Scholar
• Ono A, Westein E, Hsiao S, Nesbitt WS, Hamilton JR, Schoenwaelder SM, Jackson SP. Identification of a fibrin–independent platelet contractile mechanism regulating primary hemostasis and thrombus growth. Blood 2008;112:90–99.
   PubMed Web of Science ®Google Scholar
• Misztal T, Przesław K, Rusak T, Tomasiak M. Peroxynitrite-altered platelet mitochondria-a new link between inflammation and hemostasis. Thromb Res 2013;131:17–25.
   Google Scholar
• Misztal T, Rusak T, Tomasiak M. Peroxynitrite may affect clot retraction in human blood through the inhibition of platelet mitochondrial energy production. Thromb Res 2014;133:402–411.
   Google Scholar
• Pacher P, Beckman JS, Liaudet L. Nitric oxide and peroxynitrite in health and disease. Physiol Rev 2007;87:315–424.
   PubMed Web of Science ®Google Scholar
• van Leuven SI, Franssen R, Kastelein JJ, Levi M, Stroes ESG, Tak PP. Systemic inflammation as a risk factor for atherothrombosis. Rheumatology 2008;47:3–7.
   PubMed Web of Science ®Google Scholar
• Lamon BD, Hajjar DP. Inflammation at the molecular interface of atherogenesis. Am J Pathol 2008;173:1253–1264.
   PubMed Web of Science ®Google Scholar
• Zeerleder S, Hack CE, Wuillemin WA. Disseminated intravascular coagulation in sepsis. Chest 2005;128:2864–2875.
   PubMed Web of Science ®Google Scholar
• Pawlinski R, Mackman N. Cellular sources of tissue factor in endotoxemia and sepsis. Thromb Res 2010;125:70–73.
   PubMed Web of Science ®Google Scholar
• Levi M, van der Poll T, Buller HR. Bidirectional relation between inflammation and coagulation. Circulation 2004;109:2698–2704.
   PubMed Web of Science ®Google Scholar
• Sugiyama S, Kugiyama K, Aikawa M, Nakamura S, Ogawa H, Libby P. Hypochlorous acid, a macrophage product, induces endothelial apoptosis and tissue factor expression: involvement of myeloperoxidase-mediated oxidant in plaque erosion and thrombogenesis. Arterioscler Thromb Vasc Biol 2004;24:1309–1314.
   PubMed Web of Science ®Google Scholar
• Whiteman M, Rose P, Siau JL, Cheung NS, Tan GS, Halliwell B, Armstrong JS. Hypochlorous acid-mediated mitochondrial dysfunction and apoptosis in human hepatoma HepG2 and human fetal liver cells: role of mitochondrial permeability transition. Free Radic Biol Med 2005;38:1571–1584.
   PubMed Web of Science ®Google Scholar
• Collet JP, Montalescot G, Lesty C, Weisel JW. A structural and dynamic investigation of the facilitating effect of glycoprotein IIb/IIIa inhibitors in dissolving platelet-rich clots. Circ Res 2002;90:428–434.
   PubMed Web of Science ®Google Scholar
• Kunitada S, Fitzgerald GA, Fitzgerald DJ. Inhibition of clot lysis and decreased binding of tissue-type plasminogen activator as a consequence of clot retraction. Blood 1992; 79:1420–1427.
   Google Scholar
• Whiteman M, Szabó C, Halliwell B. Modulation of peroxynitrite- and hypochlorous acid-induced inactivation of α1- antiproteinase by mercaptoethylguanidine. Br J Pharmacol 1999;126:1646–1652.
   PubMedGoogle Scholar
• Koppenol WH, Kissner R, Beckman JS. Syntheses of peroxynitrite: to go with the flow or on solid grounds? Methods Enzymol 1996;269:296–302.
   PubMed Web of Science ®Google Scholar
• Osdoit S, Rosa J-P. Fibrin clot retraction by human platelets correlates with αIIbβ33 integrin-dependent protein tyrosine dephosphorylation. J Biol Chem 2001;273: 6703–6710.
   Google Scholar
• Luddington R. Thrombelastography/thromboelastometry. Clin Lab Haematol 2005;27:81–90.
   PubMedGoogle Scholar
• Carter AM, Cymbalista CM, Spector TD, Grant PJ. Heritability of clot formation, morphology, and lysis: the EuroCLOT study. Arterioscler Thromb Vasc Biol 2007; 27:2783–2789.
   PubMed Web of Science ®Google Scholar
• Gutmann I, Wahlefeld AW. L-(+)Lactate determination with lactate dehydrogenase and NAD. In: Bergmeyer HU (ed.). Methods of enzymatic analysis. Weiheim: VCH Velagsgesellschaft mbH; 1985. pp. 1464–1468.
   Google Scholar
• Holmsen HE, Storm E, Day HJ. Determination of ATP and ADP in blood platelets: a modification of the firefly luciferase assay for plasma. Anal Biochem 1976;46:481–502.
   Google Scholar
• Bellavite P, Andrioli G, Guzzo P, Arigliano P, Chirumbolo S, Manzato F, Santonastaso C. A colorimetric method for the measurement of platelet adhesion in microtiter plates. Anal Biochem 1994;216:444–450.
   PubMed Web of Science ®Google Scholar
• Pollock WK, Rink TJ, Irvine RP. Liberation of [3H]arachidonic acid and changes in cytoplasmic free calcium in fura-2-loaded human platelets stimulated by ionomycin and collagen. Biochem J 1986;235:869–877.
   PubMed Web of Science ®Google Scholar
• Siffert W, Siffert G, Scheid P, Akkerman JW. Activation of Na+/H + exchange and Ca2 + mobilization start simultaneously in thrombin-stimulated platelets. Evidence that platelet shape change disturbs early rises of BCECF fluorescence which causes an underestimation of actual cytosolic alkalinization. Biochem J 1989;258:521–527.
   PubMed Web of Science ®Google Scholar
• Jackson SP, Schoenwaelder SM, Yuan Y, Rabinowitz I, Salem HH, Mitchell CA. Adhesion receptor activation of phosphatidylinositol 3-kinase. Von Willebrand factor stimulates the cytoskeletal association and activation of phosphatidylinositol 3-kinase and pp60c-src in human platelets. J Biol Chem 1994;269:27093–27099.
   PubMed Web of Science ®Google Scholar
• Schoenwaelder SM, Ono A, Nesbitt WS, Lim J, Jarman K, Jackson SP. Phosphoinositide 3-Kinase p110β regulates integrin αIIbβ3 avidity and the cellular transmission of contractile forces. J Biol Chem 2010;285:2886–2896.
   PubMed Web of Science ®Google Scholar
• Seiffert D, Pedicord DL, Kieras JK, He B, Stern AM, Billheimer JT. Regulation of clot retraction by glycoprotein IIb/IIIa antagonists. Thromb Res 2002;108:181–189.
   Google Scholar
• Heemskerk JW, Mattheij NJ, Cosemans JM. Platelet-based coagulation: different populations, different function. J Thromb Haemost 2013;11:2–16.
   PubMed Web of Science ®Google Scholar
• Mattheij NJ, Gilio K, van Kruchten R, Jobe SM, Wieschhaus AJ, Chishti AH, et al. Dual mechanism of integrin αIIbβ3 closure in procoagulant platelets. J Biol Chem 2013;288:13325–13336.
   PubMed Web of Science ®Google Scholar
• Brenner C, Moulin M. Physiological roles of the permeability transition pore. Circ Res 2012;111:1237–1247.
   PubMed Web of Science ®Google Scholar
• Jackson SP, Schoenwaelder SM. Procoagulant platelets: are they necrotic? Blood 2010;116:2011–2018.
   PubMed Web of Science ®Google Scholar
• Jobe SM, Wilson KM, Leo L, Raimondi A, Molkentin JD, Lentz SR, Di Paola J. Critical role for the mitochondrial permeability transition pore and cyclophilin D in platelet activation and thrombosis. Blood 2008;111:1257–1265.
   PubMed Web of Science ®Google Scholar
• Mürer EH. Clot retraction and energy metabolism of platelets. Effect and mechanism of inhibitors. Biochim Biophys Acta 1969;172:266–276.
   PubMedGoogle Scholar
• Guppy M, Whisson ME, Sabaratnam R, Withers P, Brand K. Alternative fuels for platelet storage: a metabolic study. Vox Sang 1990;59:146–152.
   Google Scholar
• Mita H, Higashi N, Taniguchi M, Higashi A, Kawagishi Y, Akiyama K. Urinary 3-bromotyrosine and 3-chlorotyrosine concentrations in asthmatic patients: lack of increase in 3-bromotyrosine concentration in urine and plasma proteins in aspirin-induced asthma after intravenous aspirin challenge. Clin Exp Allergy 2004;34:931–938.
   PubMed Web of Science ®Google Scholar
• Higashi N, Mita H, Taniguchi M, Turikisawa N, Higashi A, Ozawa Y, et al. Urinary eicosanoid and tyrosine derivative concentrations in patients with vasculitides. J Allergy Clin Immunol 2004;114:1353–1358.
   PubMed Web of Science ®Google Scholar
• Kettle AJ, Winterbourn CC. Assays for the chlorination activity of myeloperoxidase. Methods Enzymol 1994;233:502–512.
   PubMed Web of Science ®Google Scholar